UGA Biopharma

The cell line experts for biologics and biosimilars

R2U Cells - Ready-to-Use Cell Lines

Our Ready-to-Use (R2U) Cell Lines provide a rapid start to your biologics development projects. These adapted CHO host lines are optimized for biosimilar manufacturing and rapid tech transfer, pre-validated for high productivity and stability in various production systems.

UGA Biopharma's R2U Cells offer a streamlined approach to cell line development, reducing time-to-market while maintaining the highest quality standards. Our cell lines are engineered for exceptional performance in serum-free suspension culture systems.


Key Features of R2U Cells

Our ready-to-use cell lines are designed to accelerate your biologics development process with these advanced features:

Performance Metrics

Our R2U Cells demonstrate exceptional performance across key metrics, ensuring reliable and efficient biologics production.

Productivity Comparison
Titer levels (g/L) over culture duration
3.2 g/L
Day 7
4.8 g/L
Day 10
5.6 g/L
Day 14
4.1 g/L
Day 17
5.6 g/L
Peak Titer
14 Days
Peak Time
+42%
vs Standard
Stability Profile
Productivity maintenance over generations
98%
Gen 10
95%
Gen 20
91%
Gen 30
88%
Gen 40
85%
Gen 50
85%
Gen 50
>50
Generations
+25%
Stability

R2U Cell Line Portfolio

Our portfolio includes various CHO host cell lines optimized for different applications and production requirements.

Available Cell Lines:

  • CHO-K1 R2U Cell Lines - Excellent growth characteristics for a wide range of therapeutic proteins
  • CHO-DG44 R2U Cell Lines - DHFR-deficient lines ideal for methotrexate selection and amplification
  • CHO-S R2U Cell Lines - Suspension-adapted lines for high-density culture systems
  • Custom R2U Cell Lines - Tailored solutions for specific project requirements

Ready to accelerate your biologics development with our R2U Cell Lines?

Contact our team today